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ABSTRACT
Active chromatin remodelling is integral to the DNA
damage response in eukaryotes, as damage sen-
sors, signalling molecules and repair enzymes gain
access to lesions. A variety of nucleosome remodel-
ling complexes is known to promote different stages
of DNA repair. The nucleosome sliding factors
CHRAC/ACF of Drosophila are involved in chromatin
organization during development. Involvement of
corresponding hACF1-containing mammalian nu-
cleosome sliding factors in replication, transcription
and very recently also non-homologous end-joining
of DNA breaks have been suggested. We now found
that hACF1-containing factors are more generally
involved in the DNA damage response. hACF1 de-
pletion increases apoptosis, sensitivity to radiation
and compromises the G2/M arrest that is activated
in response to UV- and X-rays. In the absence of
hACF1, cH2AX and CHK2ph signals are diminished.
hACF1 and its ATPase partner SNF2H rapidly accu-
mulate at sites of laser-induced DNA damage.
hACF1 is also required for a tight checkpoint that
is induced upon replication fork collapse. ACF1-
depleted cells that are challenged with aphidicolin
enter mitosis despite persistence of lesions and
accumulate breaks in metaphase chromosomes.
hACF1-containing remodellers emerge as global fa-
cilitators of the cellular response to a variety of dif-
ferent types of DNA damage.
INTRODUCTION
The recognition and repair of DNA damage requires that
signalling molecules and repair enzymes gain access to the
lesions, and hence necessitates extensive chromatin re-
organization. At the structural level of chromosomal
domains, the predominant mechanisms of regulating the
access to the genome involve histone modiﬁcations (1–5).
At the level of the chromatin ﬁbre nucleosome remodel-
ling enzymes are involved in all processes that assure the
integrity of complex genomes: the faithful assembly of the
chromatin ﬁbre in the context of replication, the remodel-
ling of chromatin to render lesions accessible to the repair
machinery and the regeneration of the integrity of the
chromatin ﬁbre once the DNA has been repaired.
Nucleosome remodellers modulate the interactions of his-
tones with DNA and are thus involved in nucleosome
assembly and disassembly, in the replacement of nucleo-
somal histones by variant forms and the movement and
positioning of nucleosomes on DNA (6). Their local action
on single nucleosomes may have profound effects on
higher order chromatin structure (7). Clearly, nucleosome
remodelling is an integral aspect of the cellular response to
DNA modiﬁcations induced by chemicals or UV radiation
that hinder the replication, or DNA double-strand breaks
(DSB) generated by ionizing radiation (6,8–11). Although,
the precise role of remodellers in the DNA damage
response (DDR) has only been addressed in a few cases,
evidence for chromatin opening, nucleosome clearance
and disruption of histone–DNA interactions have been
reported in experimental models, notably in yeast or upon
experimental induction of DNA breaks in mammals (6,11).
Consistent with their important roles in the DDR,
deﬁciencies in nucleosome remodelling may lead to defects
in the repair pathways, hypersensitivity of cells to DNA
damaging agents and genome instability (3,11).
Remodelling ATPases of all major families (6) are
recruited to sites of DNA damage by a variety of different
mechanisms (8,9). The recognition of a lesion by dedi-
cated surveillance factors initiates signalling cascades,
most prominently those mediated by the kinases Ataxia
Telangiectasia mutated (ATM) and ATR (ATM and
Rad3 related), which lead to local chromatin modiﬁcation.
The best known of such chromatin marks is the phosphor-
ylation of histone variant H2AX at S139, also referred to
as gH2AX (12,13). A considerable number of nucleosome
remodelling complexes, such as the yeast INO80 and
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complexes can directly interact with gH2AX-containing
nucleosomes [(14) and references therein]. A further early
response to DNA breaks is the polymerization of ADP-
ribose networks by the enzyme poly-ADP-ribose polymer-
ase (PARP). Several remodellers are concentrated at
damage sites in a PAR-dependent manner, like e.g. the
chromatin remodelling enzyme ALC1 (15,16) or CHD4,
the ATPase of the NURD complex (17–20).
Relatively, little is known about the functions of ISWI-
type remodellers in the DDR of metazoans. These evolu-
tionary conserved remodellers contain the ATPase ISWI
(in Drosophila) or their vertebrate orthologues SNF2H
and SNF2L. In contrast to the remodelling factors men-
tioned earlier, ISWI-type remodellers are not predomin-
antly known for generating access to DNA in chromatin,
but in the assembly of chromatin ﬁbres (6). Remodelling
and Spacing Factor (RSF), e.g. a complex assembled from
ISWI and RSF1, is a nucleosome assembly factor as it
combines histone chaperone and nucleosome spacing
activities (22). In the absence of RSF complex, the DNA
damage response via phosphorylation of ATM and CHK2
is compromised (23). The mammalian WICH complex,
composed of SNF2H and WSTF, may associate with
PCNA to assure the maintenance of chromatin structures
during replication (24). Remarkably, WICH may affect
the DDR by a non-remodelling mechanism as a
non-canonical H2AX kinase activity was attributed to
WSTF (25) and the survival of mouse embryonic ﬁbro-
blasts upon challenge with MMS is reduced in the absence
of WSTF (26).
We seek to understand the physiological roles of the
related ISWI-type remodelling complexes CHRomatin
Accessibility Complex (CHRAC) and ATP-dependent
Chromatin assembly and remodelling Factor (ACF).
These complexes were ﬁrst identiﬁed in Drosophila
(27,28) and subsequently found conserved in humans
(21,29). CHRAC consists of ISWI (SNF2H), ACF1 and
two small, histone-fold subunits, CHRAC14 and
CHRAC16 (hCHRAC15 and hCHRAC17 in humans)
(27,29). A complex lacking the histone-fold subunits, i.e.
only consisting of ISWI/SNF2H and ACF1, is called
ACF. The biochemical activities of CHRAC and ACF
are very similar (30,31). CHRAC and ACF are prototypic
nucleosome sliding factors; so far no nucleosome disrup-
tion activity has been detected (32,33). In vitro, ATP-
dependent nucleosome sliding can generate ‘windows of
opportunity’ for diverse DNA binding proteins, including
nucleases and prokaryotic restriction enzymes, but also
factors involved in replication, repair and recombination,
to access their targets as nucleosomes are being moved
(27,28,32,34–38). In addition, CHRAC/ACF can use
their nucleosome sliding properties to improve the integ-
rity of chromatin by ‘spacing’ nucleosomes such that gaps
are closed (27,28).
The functions of CHRAC/ACF in vivo can be assessed
by ablation of their signature subunit, ACF1. In
Drosophila, acf1 null mutants have a reduced viability.
They display a sloppy chromatin organization with
poorly distinguished eu- and heterochromatin and corres-
ponding impairment of chromatin regulation (39,40). In
human cells, depletion of hACF1 slows proliferation (41).
Varga-Weisz and colleagues found that replication of het-
erochromatin was impaired in the absence of hACF1.
Such a delay could be due to reduced chromatin opening
to allow replication or to impaired chromatin assembly in
the wake of the replication fork. Recently, Lan et al. (42)
discovered that CHRAC was targeted to induced DNA
breaks, where it apparently facilitates the association of
the Ku70/Ku80 complex with DNA ends, a prerequisite
for efﬁcient repair.
Exploring the role of hACF1 further, we found a hitherto
unappreciated involvement of hACF1 in the response of
cells to diverse DNA damages. ACF1 is quickly enriched
at sites of UV laser-induced damage. Interestingly, deple-
tion of ACF1 impairs the G2/M checkpoint as a conse-
quence of several distinct types of damaging insults:
X-ray-induced DNA breaks, UV-induced pyrimidine
dimers and the induction of replication forks collapse by
aphidicolin. The G2/M checkpoint control senses unre-
paired DNA damage and halts the progression of the
checkpoint to allow time for the cell to repair the damage
before entering mitosis. This process is compromised in
the absence of ACF1, as cells that are challenged with the
replication inhibitor aphidicolin accumulate higher levels of
DSBs in the absence of ACF1. Clearly, ACF1-containing
remodelling factors play a general role in the efﬁcient
response of cells to various types of DNA damage.
MATERIALS AND METHODS
Cell culture and irradiation
HeLa and U2OS cell lines were maintained at 37 C with
5% CO2 in Dulbecco’s modiﬁed Eagle’s medium
(DMEM, Invitrogen) supplemented with 10% foetal calf
serum (FCS, Invitrogen) and penicillin/streptomycin. UV
irradiation was performed in a Stratalinker (Stratagene) at
doses between 10 and 1000J/m
2. X-ray irradiation was
performed with a Philips MCN-X-ray tube (250kV,
13mA, 2.5+4.0mm Al and 1.0mm Cu ﬁltration) at a
dose rate of 0.56Gy/min, with ﬁnal doses between 1 and
20Gy. In both cases, cells were collected after different
times of recovery.
Aphidicolin treatment and metaphase spreads
Cells were treated with 0.1mM aphidicolin for 24h.
Colcemid (Roche) of 10mg/ml was added 1h before col-
lection. Washed cells were suspended in 8ml 75mM KCl
and incubated at 37 C for 17min. After centrifugation,
cells were ﬁxed twice with Carnoy’s ﬁxative. Cells were
spread onto a cold slide by dropping and stained with
Giemsa for 2min before washing with water. We
counted obvious chromosome breaks (Figure 1B) in 50
metaphase spreads and calculated the average number
per cell. The results from three independent experiments
yielded the numbers presented in Figure 1C.
Plasmids, antibodies and drugs
pFPN1-ACF1-GFP and pFPN1-ACF1BAZ-GFP con-
structs were a gift from P. Varga-Weisz (41). The
8446 Nucleic Acids Research, 2011,Vol.39, No. 19pFPN1-ACF1-Ntal-GFP was constructed from the pFPN1-
ACF1-GFP plasmid by cutting with ScaI and BamHI before
the WACZ domain and before GFP sequence, respectively.
The ends were ﬁlled in with Klenow polymerase and ligated.
This construct contains the N terminus including the BAZ
domain, but lacks the WACZ, PHD and bromodomains.
The following antibodies were used: ACF1 (Bethyl
Laboratories A301-318A); WSTF (Epitomics 2033-1);
SNF2H (E. Kremmer, HelmholtzZentrum, Mu ¨ nich);
CHK2T68ph (Cell Signalling 2661); tubulin (SIGMA
T9026); gH2AX (Millipore 05-636); H3S10ph (Millipore
05-806); ATMS1981ph (Cell Signalling 4526) and ATM
(Abcam ab32420).
siRNA and DNA transfections
Target sequences for small interfering (si)RNAs are desc-
ribed in Table 1. The small duplexes (MWG) were intr-
oduced with Oligofectamine and Optimem (Invitrogen)
according to the supplier’s protocol. Cells at 40–50%
conﬂuency were transfected with 200pmol siRNA and
were collected 72h later. For transient transfections of
GFP constructs with the Jetpei reagent (Peqlab), cells at
70–80% conﬂuency were transfected with 1–2mgo f
plasmid according to the manufacturer’s speciﬁcations
and samples were collected 48h later.
Clonogenic assays
Colony formation assays were performed as described (43).
In short, cells were transfected at Day 0, trypsinized and
replated in deﬁned numbers on Day 2 and irradiated 3h
later. Appropriate cell numbers were seeded in triplicates.
The plates were collected on Day 10, stained with 80%
EtOH, 0.3% methylene blue and washed three times with
water. Colonies containing >50 cells were counted
microscopically.
Cell extract preparation and western blotting
Whole-cell extracts from 2 to 3 10
6 cells were prepared
in IPH buffer (50mM Tris–HCl pH 8, 150mM NaCl,
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Figure 1. ACF1 depletion increases apoptosis and sensitivity to aphidicolin (APH). (A) Annexin V staining of U2OS and HeLa cells 72h after
transfection with siRNA1 against SNF2H or ACF1 measured by FACS analysis. PI staining allowed discarding the necrotic population. The fraction
of positive cells for each condition was determined and the values normalized to the corresponding controls, which were set to 1. (B) Examples for
metaphase chromosomes without (left) or with the types of visible breaks counted to arrive at the numbers in (C) (right). (C) Quantiﬁcation of the
number of breaks in ACF1-depleted (ACF1) and control cells (CTRL) after 24h incubation with 0.1mM of APH. Two different siRNA pairs where
used to deplete ACF1 (black: siRNA1, grey: siRNA2). From each sample 50 cells were counted. (D) Clonogenic survival of HeLa cells after ACF1
depletion and controls in response to 0.05, 0.1 or 0.5mM of APH.
Table 1. siRNA sequences for RNA interference
Target Sequence
ACF1 siRNA1 CAC UGU GAA CCA CAA GAU G
ACF1 siRNA2 TTA CAT GAG TCT GCT ATT G
SNF2H siRNA1 GAG GAG GAU GAA GAG CUA U
SNF2H siRNA2 UGA CAA GGG UAU UGG ACA U
WSTF GAA CAG GAA GUU GCU GAG C
CTRL siRNA1 CUU ACG CUG AGU ACU UCG A
CTRL siRNA2 CGU ACG CGG AAU ACU UCG A
Nucleic Acids Research, 2011,Vol.39, No. 19 84475mM EDTA, 0.5% NP-40) containing protease and
phosphatase inhibitors (Sigma). Cells were kept on ice
for 10min followed by centrifugation at 13krpm for
10min at 4 C. Protein concentration was analysed with
Bradford Reagent (Biorad). For western blot analysis,
boiled protein in sample buffer was separated on 7–15%
acrylamide gels and transferred to Protran nitrocellu-
lose membranes (Whatman). Incubation with primary
antibodies was at 4 C overnight. Secondary antibodies
were compatible with IR ﬂuorescence detection on a
LI-COR Odyssey Infrared Imaging System at medium
intensities.
Immunoﬂuorescence
Cells on cover slips were ﬁxed in 4% paraformaldehyde-
PBS for 20min and permeabilized with methanol for
10min. Alternatively, cells were ﬁxed in 3.7% formalde-
hyde and permeabilized with 0.5% Triton X-100 in PBS
for 5min. After blocking with 3% bovine serum albumin
(BSA) in PBS with 0.1% Triton X-100 (PBST) for 30min,
cells were incubated for 2h in primary antibody diluted
into 3% BSA in PBST. After three washes with PBST
cells were incubated for 1h with CY3 or Alexa488
labelled secondary antibodies. Cells were mounted onto
a slide with Vectashield (Vector Laboratories) containing
DAPI (40,60-diamidino-2-phenylindole). Confocal images
(512   512pixels) from three different channels were col-
lected with a Leica SP5 microscope equipped with a
Plan-Apochromat 63 /1.4 oil immersion objective.
Flow cytometry
Apoptotic cells were detected with an Annexin V
Apoptosis Detection Kit (Biovision). Cells (1.5 105)
were collected by centrifugation and suspended in 0.5ml
of buffer containing calcium. Annexin V-conjugated with
FITC and PI were added to the sample, which was
incubated at room temperature (RT) for 5min in the
dark. The percentage of Annexin V-FITC positive cells
without PI staining was determined and normalized to
the control cells. To measure H3S10ph, cells were washed
twice in PBS, ﬁxed in 70% ethanol for 1h at  20 C and
stained with a 1:100 dilution of the primary antibody for
2h at RT. After washing, cells were incubated for 1h at
RT in the dark with Alexa488-conjugated secondary
antibody. DNA staining for analysis of cell cycle phases
was done with cells ﬁxed in 70% ethanol for 1h at  20 C
using 25ml PI (1mg/ml) and 5ml RNase (10mg/ml). To
analyse cells with subG1 DNA content the culture was
harvested 96h after siRNA treatment. Data were collected
with BD FACSCANTO and analysed with BD
FACSDIVA software (BD Biosciences).
Live-cell microscopy and laser microirradiation
Live cell imaging and micro-irradiation experiments were
carried out with a PerkinElmer UltraView Vox spinning
disk microscope equipped with a Plan-Apochromat
63 /1.4 oil objective using Volocity software 5.3 for
image capturing. GFP and RFP were excited with
488nm and 561nm DPSS laser lines, respectively. The
microscope was equipped with a heated environmental
chamber set to 37 C. Confocal image series were typically
recorded with a frame size of 256 256pixels and a pixel
size of 109nm.
For localized DNA damage induction, cells were seeded
inm-slides VI or griddedm-dishes (ibidi) and sensitized by
incubation in DMEM supplemented with 10% FCS and
50mg/ml gentamicin-containing BrdU (10mg/ml) for
24–48h at 37 C. Prior to live-cell imaging, the medium
was changed to phenol-red-free medium containing
25mM HEPES. Micro-irradiation was performed using
the FRAP preview mode of the Volocity software by re-
peatedly scanning (1200 iterations) a preselected stripe
(18 0.5mm) within the nucleus with a 405nm diode
laser set to 50mW, which leads to generation of a detect-
able DDR in a pre-sensitization-dependent manner. The
laser power was measured after passing through the ob-
jective lens with a laser power meter (Coherent). Before
and after micro-irradiation confocal image series of one
mid z-section were recorded at 2s time interval (typically
6 pre-irradiation and 150 post-irradiation frames). For
evaluation of the recruitment kinetics, ﬂuorescence
intensities at the irradiated region were corrected for back-
ground and for total nuclear loss of ﬂuorescence over the
time course and normalized to the pre-irradiation value.
For the quantitative evaluation of micro-irradiation ex-
periments, data of at least 10 nuclei were averaged and
the mean curve and the standard error of the mean
calculated and displayed using Microsoft Excel software.
Statistical analysis
All quantiﬁcations are based on three independent experi-
ments. For every sample, the mean value and error
bars, representing the standard deviation, are calculated.
For analyses of signiﬁcance a two-tailed Fisher’s exact
test was used with the exception of the analysis of
Supplementary Figure S5B, for which a one-tailed test
was employed and P-values represented with one
asterisk (*) if P<0.05, two (**) if P<0.01 and three
(***) if P<0.001.
RESULTS
ACF1 depletion leads to apoptosis
Depletion of ACF1, the signature subunit of CHRAC/
ACF complexes, was previously shown to impair prolifer-
ation in HeLa cells (41). We conﬁrmed these results in
HeLa and U2OS cells, in which expression of hACF1
and the associated SNF2H ATPase subunit can be efﬁ-
ciently reduced by RNA interference (44). Two days after
transfection of small-interfering RNA duplex oligonucleo-
tides (siRNA) ACF1 expression was already strongly
reduced (Supplementary Figure S1A). After 3 days the
ACF1 knockdown led to reduced proliferation of HeLa
cells when compared to a parallel culture treated with
control siRNA (Supplementary Figure S1B). Depletion
of the ATPase SNF2H resulted in a similar proliferation
defect (Supplementary Figure S1A and S1B), which is in
agreement with the previously suggested role for these
proteins in replication (41,45). In either case, the expres-
sion of the related WSTF was unaffected (Supplementary
8448 Nucleic Acids Research, 2011,Vol.39, No. 19Figure S1C). However, we also observed increased cell
death in the cultures that were depleted of SNF2H or
ACF1. We quantiﬁed the binding of ﬂuorescent Annexin
V to accessible phosphatidylserine in the outer cell mem-
brane by cytometry, as a measure of early apoptotic
events. Annexin V levels were increased in U2OS and
HeLa cells when ACF1 or SNF2H were depleted
(Figure 1A and Supplementary Figure S1D). Similar in-
creases were seen if the remodeller subunits were depleted
with a second pair of siRNA oligonucleotides, excluding a
dominant off-target effect (Supplementary Figure S1D
and S1E). The apoptotic phenotype was conﬁrmed by
ﬂuorescence-activated cell scanning (FACS), measuring
the DNA content by propidium iodide (PI) staining.
Cells with reduced expression of ACF1 or SNF2H
showed enhanced cell fragmentation as a marker of late
apoptosis, indicated by cells with lower than G1 DNA
content (Supplementary Figure S1F and data not
shown). It is known that SNF2H is required for viability
in vivo (46) and that depletion of SNF2H in tissue culture
cells leads to apoptosis (25), yet it was unexpected that
depletion of ACF1 had similar consequences. An
increased apoptosis rate may indicate an accumulation
of DNA damage due to increased replication defects,
compromised repair or incomplete checkpoint activation.
These possibilities led us to explore the consequences of
reduced ACF1 levels after DNA damage induction.
Depletion of ACF1 increases aphidicolin-induced
chromosomal fragility
Varga-Weisz and colleagues (41) suggested that the deple-
tion of ACF1 leads to a delay in the later stages of repli-
cation. Partial inhibition of DNA polymerase a with
aphidicolin is known to particularly affect late replication:
in the presence of the inhibitor some late replicating
chromosomal areas may end up not being replicated,
which leads to visible breaks in metaphase chromosomes,
also known as ‘fragile sites’ (47–51). We therefore tested
whether ACF1 depletion increases the aphidicolin-induced
replication stress by monitoring metaphase chromosome
breaks. HeLa cells were incubated with 0.1mM aphidicolin
for 24h treated with colcemid and metaphase spreads were
visually inspected for chromosome breaks (Figure 1B).
Depletion of ACF1 with two different siRNAs led to a
signiﬁcant increase in the number of chromosome breaks,
when compared to the RNAi control (Figure 1C). In the
absence of aphidicolin, only very few breaks were observed
and the number of breaks were not increased if ACF1 was
depleted. This may indicate that depletion of ACF1 does
not lead to replication fork collapse itself, but diminishes
the recovery from such damage. In support of this idea,
the survival of HeLa cells challenged with aphidicolin at
concentrations between 0.05 and 0.5mM is strongly
reduced upon depletion of ACF1 (Figure 1D).
Treatment of cells with aphidicolin can induce intra-S
and G2/M checkpoints (50). The incubation of HeLa
cells with 0.1mM aphidicolin generated chromosome
breaks without noticeable alterations in the cell cycle,
but higher doses of the inhibitor lead to S-phase arrest,
which is not modiﬁed by ACF1 knockdown (data not
shown). U2OS cells mount a G2/M arrest at low doses
of aphidicolin and accumulate high levels of damage in
metaphase chromosomes (Figure 2A and data not shown).
In the absence of ACF1, an increased number of S phase
intermediates were observed and at the same time the G2/
M peak was diminished (Figure 2A). In order to discrim-
inate between cells in G2 and M phases, we combined
PI staining with staining for histone H3 phosphorylated
at serine 10 (H3S10ph), a chromatin mark for mitotic cells
(52). Whereas aphidicolin treatment decreases the percent-
age of mitotic cells after G2/M checkpoint activation in
control cells, this population is increased signiﬁcantly after
ACF1 knockdown (Figure 2B and C), indicating that
ACF1 is required for proper checkpoint activation.
ACF1 modulates the response of cells to damaging
radiation
Our data documented a role for ACF1 in the response to
replication-associated DNA breaks, which raised the ques-
tion as to whether ACF1 was also involved in the cellular
response to other types of damage. In support of this hy-
pothesis, Lan et al. (42) recently reported that ACF1 is
involved in the repair of X-ray-induced DNA breaks. In
an independent, parallel effort, we explored the relation-
ship between ACF1 and the response of cells to UV- and
X-rays. U2OS cells, in which ACF1 had been depleted for
48h, and appropriate controls were irradiated with differ-
ent doses of UV- and X-rays and their survival was moni-
tored in a clonogenic assay (Supplementary Figure S2A).
Our data conﬁrm and complement the ones of Lan et al.
(42). At doses of X-ray below 3–4Gy the depletion of
ACF1 has a minor effect on cell survival [Supplementary
Figure S2A, (42)]. ACF1-depleted cells show an increased
sensitivity against higher doses of X-ray (6 and 9Gy) (42).
Lan et al. (42) concluded that the sensitivity of cells
towards low doses of UV irradiation (up to 10J/m
2) was
not severely affected, but we found a moderate sensitiza-
tion at higher doses of UV (Supplementary Figure S2A).
In order to conﬁrm these results, we used apoptosis as a
surrogate marker for cell viability at high irradiation doses.
HeLa and U2OS cells were irradiated with 100J/m
2 or
10Gy, allowed to recover for 24h and stained for
Annexin V to monitor apoptosis. Cells with reduced
ACF1 levels showed increased apoptosis in response to
both, UV- and X-ray (Supplementary Figure S2B).
Since several of the known nucleosome remodelling
factors are directly recruited to sites of radiation damage
(15,17,53), we wished to characterize ACF1 in this respect.
Local DNA damage was introduced into BrdU-sensitized
HeLa cells by micro-irradiation with a 405nm laser. The
track of DNA damage was marked by a line of diagnostic
gH2AX modiﬁcation. We found that endogenous ACF1
quickly localized to laser-induced DNA lesions colocal-
izing with the damage marker gH2AX (Figure 3A). In
addition we detected recruitment of the ACF1 ATPase
partner SNF2H to laser-induced DNA damage sites,
as well as recruitment of the ACF1-related WSTF
(Supplementary Figure S3A), which had been proposed to
be necessary for the long-term maintenance of gH2AX
(25). To analyse the in vivo kinetics of ACF1 recruitment,
Nucleic Acids Research, 2011,Vol.39, No. 19 8449we transiently expressed GFP-tagged ACF1 together with
RFP-PCNA as a positive control and followed the real-
time accumulation of both proteins after damage induc-
tion in living cells. We found that ACF1-GFP, like
PCNA, accumulated at DNA damage sites within 30s
after irradiation (54) (Figure 3B and Supplementary
Figure S3B). The C-terminus of ACF1, containing the
PHD and bromodomain modules, was not required for
efﬁcient recruitment. Interestingly, the N-terminal
fragment of ACF1 showed an even faster accumulation
than the full length ACF1 (Figure 3C and D). This
change in the t1/2 might be due to a weaker retention of
the protein at other chromatin targets leading to faster
redistribution. The recruitment of the N-terminal part of
ACF1 can be explained by the presence of several poten-
tial targeting surfaces, such as the BAZ domain that
mediates the SNF2H interaction (41) and an interaction
surface for the CHRAC17/CRAC15 subunits (31). An
additional potential DNA binding determinant had been
observed for the Drosophila ACF1 homolog in the ACF1
N terminus (55). ACF1-GFP and SNF2H-GFP accumu-
lated with very similar kinetics (Supplementary
Figure S3B and S3C). In order to test, to which extent
ACF1 recruitment depends on the SNF2H interaction
we expressed a protein lacking the BAZ domain, which
mediates the SNF2H interaction (ACF1-BAZ) (41).
Deletion of the BAZ domain led to a signiﬁcant decrease
in ACF1 recruitment (Figure 3C and D). This highlights
an important, but not exclusive, contribution of the
SNF2H interaction for ACF1 recruitment. Our data are
in good agreement with recent ﬁndings that SNF2H and
ACF1 accumulate at UV laser-induced tracks of damaged
chromatin in U2OS cells (42,56).
The radiation-induced G2/M checkpoint is incomplete in
the absence of ACF1
The above-mentioned data ﬁrmly establish a role for
ACF1 in the cellular response to radiation damage. The
observation that ACF1 depletion compromised the G2/M
checkpoint after replication stress prompted us to test
whether ACF1 also plays a role in G2/M checkpoint ac-
tivation after UV/X-ray irradiation. ACF1-depleted HeLa
cells were irradiated with X-rays at 10Gy and the cell
cycle distribution was monitored after different time
points by FACS analysis. Control cells showed a
profound G2/M arrest, which was moderately reduced
after ACF1 knockdown (Figure 4A). In order to discrim-
inate between cells in G2 and M phases we combined PI
staining with staining for histone H3S10ph as before.
Control HeLa cells or ACF1-depleted cells were irradiated
with UV (100J/m
2) or X-ray (1Gy). The quantiﬁcation of
the mitotic fraction of control cells revealed a clear reduc-
tion after both UV and X-ray irradiation, as expected
from an intact G2/M checkpoint arrest (Figure 4B).
Remarkably, upon depletion of ACF1 up to 2-fold more
mitotic cells were observed, suggesting that the G2/M
checkpoint was not properly activated particularly after
short recovery times (Figure 4C and D). The same
results were obtained with U2OS cells and using two dif-
ferent siRNAs against ACF1 (Supplementary Figure S4A
and S4B, respectively). Most proteins involved in check-
point activation are individually dispensable for a proper
arrest at high levels of damage when more than one repair/
signalling pathway is active (59). However, we found more
mitotic cells in the absence of ACF1 even at much higher
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Figure 2. ACF1 depletion compromises the G2/M checkpoint after
APH treatment. (A) Control U2OS cells (CTRL) or cells depleted of
ACF1 (ACF1) by treatment with siRNAs for 72h were incubated with
0.3mM APH for 24h. Cells were harvested, ﬁxed and the cell cycle
distribution was analysed by DNA staining with PI. (B) Control cells
(CTRL) or ACF1-depleted U2OS cells (ACF1) were incubated for 24h with
0.3mM APH. Cells were sorted by DNA content (PI staining) and the
mitosis marker H3S10ph. Double-positive cells are labelled by green
dots. (C) Quantiﬁcation of mitotic cells for U2OS upon ACF1
knockdown after incubation of 2h with 1mM or 24h with 0.3mM APH.
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2 UV and 10Gy X-rays;
Supplementary Figure 4C). Interestingly, in contrast to
the results obtained after ACF1 knockdown, depletion
of WSTF (Supplementary Figure S1C), the non-catalytic
subunit of the WICH complex, which is involved in signal
transduction upon DSB induction (25), leads to reduced
rather than increased numbers of mitotic cells (Figure 4C
and D). Apparently, ACF1-containing remodellers, but
not the WICH complex, contribute to activating the G2/
M checkpoint arrest.
One of the main markers of DNA damage, phosphor-
ylation of H2AX at serine 139 (gH2AX), is necessary
for signal ampliﬁcation upon DNA damage but dispens-
able for initial recognition of the damage (58). To further
investigate the role of ACF1 in G2/M checkpoint activa-
tion, we analysed gH2AX levels in ACF1-depleted cells
that were damaged in various ways. In support of our pre-
vious results, ACF1 depletion led to reduced levels of
gH2AX after aphidicolin treatment and irradiation
(Figure 5A), even allowing for 24h of recovery
after X-ray irradiation (Supplementary Figure S5A).
ATMS1981ph and CHK2T68ph are two phosphorylation
marks that characterize the G2/M checkpoint (12,57,52).
While we observed a reduction of CHK2T68ph upon
Figure 3. Recruitment of ACF1 to laser-induced DNA damage sites. (A) Endogenous ACF1 accumulates at laser-induced DNA damage sites.
Confocal images of HeLa cells ﬁxed at indicated time points after laser micro-irradiation and stained for ACF1 and the DNA damage marker
gH2AX are shown. (B) Live imaging of MEFs expressing either full-length ACF1 (ACF1-GFP), a deletion construct missing the BAZ domain
(ACF1-BAZ-GFP) or the N-terminal part of ACF1 (ACF1-Nter-GFP) together with RFP-PCNA. (C) Quantitative evaluation of recruitment
kinetics shown in (B). (D) Graphs showing the halftime of recruitment (t1/2), which is the time needed for reaching half of the ﬁnal intensity at the
micro-irradiated area and the Max Int, which is the ﬁnal intensity at the micro-irradiated area reached within the observation period of 5min, for the
indicated ACF1 fusion proteins. Scale bar, 5mm.
Nucleic Acids Research, 2011,Vol.39, No. 19 8451ACF1 depletion, ATMS1981ph appeared hardly affected,
considering that a slight overall reduction of ATM levels
cannot be excluded (Figure 5B). In order to quantify and
provide a measure of reproducibility, we performed add-
itional X-ray irradiation experiments with varying doses
and 1h of recovery and quantiﬁed the resulting western
blots using a LI-COR Odyssey Infrared Imaging System.
The band intensities from triplicates were normalized to
the tubulin signals in the same lane (Figure 5C). The data
show a clear reduction of the gH2AX signal in
ACF1-depleted cells. We also attempted to obtain inde-
pendent conﬁrmation for the reduction by staining cells
with antibodies against gH2AX after UV- and X-ray ir-
radiation and measuring the mean intensity of the popu-
lation by FACS. ACF1 depletion yields a modest decrease
in the intensity of gH2AX, although at this depth of
analysis the data merely illustrate a trend
(Supplementary Figure S5B). Direct visualization of im-
munoﬂuorescence staining of gH2AX yields qualitative
support (Supplementary Figure S5C). In summary, our
results demonstrate that at reduced ACF1 levels the sig-
naling of DNA damage is impaired.
In their parallel effort, Lan et al. (42) counted the
number of foci per cell or the number of cells with foci
at different times after irradiation and observed an increase
of gH2AX foci after longer recovery times (24–48h).
Conceivably, the persistence of gH2AX foci reﬂect the
function of ACF1 in repair, whereas the reduction of
overall gH2AX levels early reﬂect its involvement in the
initial signalling that sets the G2/M checkpoint.
DISCUSSION
ACF1 and checkpoint control
Probing the integrity of the G2/M checkpoint in the
context of replication fork collapse, UV-induced pyrimi-
dine dimers and X-ray-induced DSB we found diminished
checkpoint activation in the absence of ACF1. Entering
mitosis with unrepaired DNA lesions due to a faulty
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2.( D) The same as in (C) with
1Gy X-ray irradiation.
8452 Nucleic Acids Research, 2011,Vol.39, No. 19G2/M checkpoint can have severe consequences as this
may lead to generation of more damage, chromosome
breaks, aneuploidy or malignant transformation (60,61).
We showed the increased number of DNA breaks in meta-
phase chromosomes in the absence of ACF1 after
inducing replicative stress with aphidicolin. So far, the
only known molecular context for ACF1 is the association
with the ATPase SNF2H in the nucleosome remodelling
factors ACF and CHRAC. We conclude that ACF1—and
by inference the remodelling factors it deﬁnes—is involved
in the cellular response to several distinct types of DNA
lesions. Interestingly, unbalanced expression of another
SNF2H interactor, RSF1, can lead to DNA breaks and
chromosome instability (23). It is unknown, whether dif-
ferent SNF2H interactors compete with the common
ATPase and whether an increase of RSF would lead to
reduced CHRAC/ACF complexes.
While this manuscript was in preparation, Lan et al.
(42) described a role for ACF/CHRAC in DSB repair.
Their data suggested that ACF1 facilitates the loading
of the KU complex to chromosomal breakpoints, but
did not address the consequences for checkpoint arrest.
In this context, our ﬁnding of an impaired G2/M arrest
upon depletion of ACF1 has important implications.
Depletion of repair factors usually leads to an increase
in the G2/M checkpoint. For example, it has been sug-
gested that KU80 deﬁciency in mammalian cells or KU70
in yeast leads to stronger G2/M checkpoint (62,63).
Apparently, ACF1 contributes to both processes: repair
and checkpoint activation. The combined loss of these
functions is expected to lead to dramatic consequences,
as continued proliferation in the presence of DNA
damage predisposes cells for chromosomal instability
and malignant translocations (60,61). However, consistent
with the known roles for nucleosome remodelling factors
as facilitators of chromosomal interactions rather than
primary targeting determinants the contributions of
ACF1 appear modulatory, rather than decisive.
In the context of DSB repair, interactions between
ACF1 and KU70 were recently shown to be important.
In the absence of ACF1, reduced levels of KU70/80 were
found at DSB (42). The checkpoint defects we found here
cannot be explained by reduced KU loading since this
would normally lead to a hyperactive G2/M arrest
(62,63). Furthermore, KU is not involved in the repair
of pyrimidine dimers or coping with replication stress.
Therefore, we speculate that ACF1 has a broader role in
promoting the G2/M checkpoint in response to diverse
types of DNA damage and it will be interesting to
dissect its role in these diverse scenarios.
Targeting ACF
The different recruitment kinetics of repair proteins to
DNA lesions provide a ﬁrst indication on their respective
role in the DDR. The fast and early recruitment of ACF1
to sites of laser-induced lesions parallels that of the sliding
clamp PCNA. This is unlikely to be due to direct inter-
action with PCNA (24), but may at least in part be
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Figure 5. ACF1 depletion diminishes H2AX, CHK2 and ATM phosphorylation. (A) ACF1-depleted HeLa cells and controls received the following
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intensities are normalized to the loading control tubulin and relative to the control without irradiation.
Nucleic Acids Research, 2011,Vol.39, No. 19 8453explained by direct binding to the KU complex (42). This
early recruitment supports our hypothesis that ACF1 acts
upstream of the checkpoint signalling marks gH2AX and
phospho-CHK2. In yeast the presence of the gH2AX
modiﬁcation serves as a reference for the approximate
timing of factor recruitment. A number of remodelling
complexes have been described to accumulate at lesion
sites before or after the appearance of gH2AX (8). For
instance, RSC is recruited rapidly, although still slower
than mammalian ACF1, during the ﬁrst 10min after
damage induction (64) and it has been proposed to be
responsible for H2AX phosphorylation along with SWI/
SNF. This is in contrast to the Ino80 complex, whose re-
cruitment depends on prior gH2AX modiﬁcation (65,66).
However, not all remodellers that are recruited to the
lesion site early play similar roles. For example, the mam-
malian SWI/SNF complex is recruited to DSBs early and
is involved in stimulating the phosphorylation of H2AX,
but depletion of critical subunits had no effect on the es-
tablishment of the G2/M checkpoint (67,53).
The dichotomy in the relationship between remodellers
and the G2/M checkpoint is perhaps best illustrated by
our experiment, in which we depleted cells in parallel of
either ACF1 or the related WSTF protein, which associ-
ates with SNF2H to form the WICH complex (24,25,45).
Depletion of WSTF leads to a stronger G2/M checkpoint,
whereas ACF1 depletion renders the checkpoint leaky.
A global role for ACF1 in the DNA damage response?
The role of ACF1 in the DDR we identiﬁed here is rem-
iniscent of the CHD4-containing NuRD complex, which is
recruited within 30s after micro-irradiation and is
required for an intact G2/M checkpoint (18,19). CHD4
depletion affects the levels of RNF168-dependent
ubiquitination at lesion sites, which presumably has
many substrates. The identiﬁcation of more functional
and physical interactors of ACF1 will help to elucidate
the role of ACF1 in the damage response pathway. The
fact that ACF1 is required for loading of the KU complex
onto DSBs is in line with its biochemical property to
render DNA accessible by nucleosome sliding
(27,28,32,34–38). However, such a role has not yet been
documented in vivo. Loss- and gain-of-function studies of
ACF1 in Drosophila suggest a role for ACF1-containing
remodellers in the assembly of intact chromatin ﬁbres as a
prerequisite for higher order chromatin organization
(39,40). Therefore, we also consider a role for CHRAC/
ACF as a repair factor specialized to deal with the chro-
matin aspect of the repair process. Any repair of the
damaged DNA needs to be followed by reconstitution of
chromatin integrity. The known biochemical properties of
CHRAC/ACF in nucleosome assembly and nucleosome
spacing are perfectly suited to fulﬁll the task of chromatin
ﬁbre repair. It will be interesting to explore, whether per-
sistent defects at the level of chromatin organization can
be sensed to delay cell cycle progression.
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